(VIANEWS) – UP Fintech Holding Limited (TIGR), Assured Guaranty Ltd. (AGO), First Solar (FSLR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. UP Fintech Holding Limited (TIGR)
357.3% sales growth and 5.49% return on equity
UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform; and account management services. The company also provides trade execution, margin financing, and securities lending services; asset management and wealth management; ESOP management; fund license application, product design, asset custody, transaction execution, and funding allocation; fund structuring and management; and IPO underwriting services. In addition, it offers market information, community engagement, investor education, and simulated trading services. UP Fintech Holding Limited was founded in 2014 and is based in Beijing, China.
Earnings Per Share
As for profitability, UP Fintech Holding Limited has a trailing twelve months EPS of $0.1.
PE Ratio
UP Fintech Holding Limited has a trailing twelve months price to earnings ratio of 82.8. Meaning, the purchaser of the share is investing $82.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.49%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 25% and positive 500% for the next.
2. Assured Guaranty Ltd. (AGO)
142.7% sales growth and 13.25% return on equity
Assured Guaranty Ltd., through its subsidiaries, provides credit protection products to public finance, infrastructure, and structured finance markets in the United States and internationally. The company operates in two segments, Insurance and Asset Management. It offers financial guaranty insurance that protects holders of debt instruments and other monetary obligations from defaults in scheduled payments. The company insures and reinsures various debt obligations, including bonds issued by the United States state, governmental authorities, or municipal governmental authorities; and notes issued to finance infrastructure projects. It also insures and reinsures various types of the U.S. public finance obligations, such as general obligation, tax-backed, municipal utility, transportation, healthcare, higher education, infrastructure, housing revenue, investor-owned utility, renewable energy, and other public finance bonds; non-U.S. public finance obligations comprising regulated utilities, infrastructure finance, sovereign and sub-sovereign, renewable energy bonds, pooled infrastructure, and other public finance obligations; and the U.S. and non-U.S. Structured finance obligations, including residential mortgage-backed securities, insurance securitization obligations, consumer receivables securities, pooled corporate obligations, financial products, and other structured finance securities. In addition, the company provides asset management services comprising investment advisory services, including management of collateralized loan obligations and opportunity funds to outside investors. It markets its financial guaranty insurance directly to issuers and underwriters of public finance and structured finance securities, as well as to investors in such obligations. Assured Guaranty Ltd. was founded in 2003 and is headquartered in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Assured Guaranty Ltd. has a trailing twelve months EPS of $12.21.
PE Ratio
Assured Guaranty Ltd. has a trailing twelve months price to earnings ratio of 6.51. Meaning, the purchaser of the share is investing $6.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.25%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 39.2%, now sitting on 834M for the twelve trailing months.
3. First Solar (FSLR)
36.6% sales growth and 18.11% return on equity
First Solar, Inc., a solar technology company, provides photovoltaic (PV) solar energy solutions in the United States, France, Japan, Chile, and internationally. The company manufactures and sells PV solar modules with a thin film semiconductor technology that provides a lower-carbon alternative to conventional crystalline silicon PV solar modules. It designs, manufactures, and sells cadmium telluride solar modules that converts sunlight into electricity. The company's residual business operations include project development activities, operations and maintenance services, and the sale of PV solar power systems to third-party customers. It serves developers and operators of systems, utilities, independent power producers, commercial and industrial companies, and other system owners. The company was formerly known as First Solar Holdings, Inc. and changed its name to First Solar, Inc. in 2006. First Solar, Inc. was founded in 1999 and is headquartered in Tempe, Arizona.
Earnings Per Share
As for profitability, First Solar has a trailing twelve months EPS of $11.21.
PE Ratio
First Solar has a trailing twelve months price to earnings ratio of 20.62. Meaning, the purchaser of the share is investing $20.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.11%.
Yearly Top and Bottom Value
First Solar’s stock is valued at $231.13 at 01:22 EST, way under its 52-week high of $306.77 and way above its 52-week low of $129.22.
Previous days news about First Solar(FSLR)
- According to Zacks on Wednesday, 9 October, "A few notable forerunners in this industry that solar investors may keep in their portfolio are First Solar (FSLR Quick QuoteFSLR – Free Report) , Enphase Energy (ENPH Quick QuoteENPH – Free Report) and FTC Solar (FTCI Quick QuoteFTCI – Free Report) .", "On Sept. 6, 2024, First Solar inaugurated its new $1.1 billion fully vertically integrated thin-film solar manufacturing facility in Lawrence County, AL. "
4. Halozyme Therapeutics (HALO)
33.4% sales growth and 153.16% return on equity
Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; XYOSTED, an injection for SC administration of testosterone replacement therapy; NOCDURNA, a sublingual tablet to treat nocturia due to nocturnal polyuria; TLANDO, an oral formulation for testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of multiple blood cancer; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergy and immunology; Sumatriptan injection for migraines; exenatide and teriparatide injections; Makena, a progestin drug to reduce the risk of preterm birth; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $2.58.
PE Ratio
Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 22.94. Meaning, the purchaser of the share is investing $22.94 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 153.16%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 32% and 56.1%, respectively.
5. Fluor Corporation (FLR)
24.4% sales growth and 15.9% return on equity
Fluor Corporation provides engineering, procurement, and construction (EPC); fabrication and modularization; operation and maintenance; asset integrity; and project management services worldwide. It operates through four segments: Energy Solutions, Urban Solutions, Mission Solutions, and Other. The Energy Solutions provides solutions to the energy transition markets, including asset decarbonization, carbon capture, renewable fuels, waste-to-energy, green chemicals, hydrogen, nuclear power, and other low-carbon energy sources. It also provides consulting services, including feasibility studies, process assessments, and project finance structuring; and a range of services for small modular reactor technologies, as well as operation support services for nuclear power facilities and managing waste. This segment serves the oil, gas, and petrochemical industries. The Urban Solutions segment offers EPC and project management services to the infrastructure, advanced technologies, life sciences, and mining and metals industries. This segment also provides staffing services to the company and third-party clients with technical, professional, and craft resources on a contract or permanent placement basis. The Mission Solutions offers technical solutions to the U.S. and other governments. It also delivers solutions for nuclear security and operation, nuclear waste management, and laboratory management; and operation and maintenance, logistics, EPC, and life support solutions for mission-critical facilities across U.S. military service organizations. This segment offers site management, environmental remediation, and decommissioning for nuclear remediation at governmental facilities, as well as services to commercial nuclear clients. The Other segment researches, develops, licenses, and commercializes small modular nuclear reactor technology. It also provides unionized management and construction services. The company was founded in 1912 and is headquartered in Irving, Texas.
Earnings Per Share
As for profitability, Fluor Corporation has a trailing twelve months EPS of $2.32.
PE Ratio
Fluor Corporation has a trailing twelve months price to earnings ratio of 20.47. Meaning, the purchaser of the share is investing $20.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.9%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.3%, now sitting on 15.74B for the twelve trailing months.
Sales Growth
Fluor Corporation’s sales growth for the next quarter is 24.4%.
Previous days news about Fluor Corporation(FLR)
- According to Zacks on Tuesday, 8 October, "The company is also benefiting from improved production efficiencies, supported by ongoing investments in personnel and equipment.MPTI stock also outpaced its competitors like KBR, Inc. (KBR Quick QuoteKBR – Free Report) , Fluor Corporation (FLR Quick QuoteFLR – Free Report) and AECOM (ACM Quick QuoteACM – Free Report) , which gained 10.9%, 14.7% and 11.4%, respectively, in the past month."
6. Crexendo (CXDO)
9.8% sales growth and 6.24% return on equity
Crexendo, Inc. provides cloud communication platform and services, video collaboration, and managed IT services for businesses in the United States, Canada, and internationally. It operates through two segments, Cloud Telecommunications and Software Solutions. The Cloud Telecommunications segment provides telecommunications services that transmit calls using Internet protocol (IP) or cloud technology, which converts voice signals into digital data packets for transmission over the Internet or cloud; and broadband Internet services. This segment is also involved in the sale and lease of cloud telecommunications equipment. In addition, it offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over high-speed internet connection through various devices and user interfaces, such as desktop phones and/or mobile, and desktop applications under the Crexendo brand name. The Software Solutions segment provides suite of unified communications, video conferencing, collaboration, and contact center solutions. This segment also offers SNAPsolution, a IP-based platform; and SNAPaccel, a software-as-a-service based software, as well as provides subscription maintenance and support, and professional services, including consulting, technical support, resident engineer, design, and installation services. The company was formerly known as iMergent, Inc. and changed its name to Crexendo, Inc. in May 2011. Crexendo, Inc. was incorporated in 1995 and is based in Tempe, Arizona.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.24%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 30, 2023, the estimated forward annual dividend rate is 0.02 and the estimated forward annual dividend yield is 0.41%.
Sales Growth
Crexendo’s sales growth for the next quarter is 9.8%.
Moving Average
Crexendo’s worth is under its 50-day moving average of $4.52 and below its 200-day moving average of $4.52.
7. EZCORP (EZPW)
7.7% sales growth and 10.15% return on equity
EZCORP, Inc. provides pawn services in the United States and Latin America. The company operates through three segments: U.S. Pawn, Latin America Pawn, and Other Investments. The company offers pawn loans collateralized by tangible personal property, jewelry, consumer electronics, tools, sporting goods, and musical instruments. It also retails merchandise, primarily collateral forfeited from pawn lending operations and pre-owned merchandise purchased from customers. In addition, the company provides EZ+, a web-based application that allow customers to manage their pawn transactions, layaways, and loyalty rewards online. Further, it operates under the EZPAWN, Value Pawn & Jewelry, Empeño Fácil, Cash Apoyo Efectivo, GuatePrenda, and MaxiEfectivo brands. EZCORP, Inc. was incorporated in 1989 and is headquartered in Austin, Texas.
Earnings Per Share
As for profitability, EZCORP has a trailing twelve months EPS of $1.2.
PE Ratio
EZCORP has a trailing twelve months price to earnings ratio of 9.5. Meaning, the purchaser of the share is investing $9.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.15%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 13% and 8.3%, respectively.
